Literature DB >> 11015496

Fermentation by gut microbiota cultured in a simulator of the human intestinal microbial ecosystem is improved by supplementing a soygerm powder.

P De Boever1, B Deplancke, W Verstraete.   

Abstract

An in vitro model, designated the Simulator of the Human Intestinal Microbial Ecosystem (SHIME), was used to study the effect of a soygerm powder rich in beta-glycosidic phytoestrogenic isoflavones on the fermentation pattern of the colon microbiota and to determine to what extent the latter metabolize the conjugated phytoestrogens. Initially, an inoculum prepared from human feces was introduced into the reactor vessels and stabilized over 3 wk using a culture medium. This stabilization period was followed by a 2-wk control period during which the microbiota were monitored. The microbiota were then subjected to a 2-wk treatment period by adding 2.5 g/d soygerm powder to the culture medium. The addition resulted into an overall increase of bacterial marker populations (Enterobacteriaceae:, coliforms, Lactobacillus: sp., Staphylococcus: sp. and Clostridium: sp.), with a significant increase of the Lactobacillus: sp. population. The short-chain fatty acid (SCFA) concentration increased approximately 30% during the supplementation period; this was due mainly to a significant increase of acetic and propionic acids. Gas analysis revealed that the methane concentration increased significantly. Ammonium and sulfide concentrations were not influenced by soygerm supplementation. Use of an electronic nose apparatus indicated that odor concentrations decreased significantly during the treatment period. The beta-glycosidic bonds of the phytoestrogenic isoflavones were cleaved under the conditions prevailing in the large intestine. The increased bacterial fermentation after addition of the soygerm powder was paralleled by substantial metabolism of the free isoflavones (genistein, daidzein and glycitein), resulting in recovery of only 12-17% of the supplemented isoflavones.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11015496     DOI: 10.1093/jn/130.10.2599

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  34 in total

1.  Immobilization of infant fecal microbiota and utilization in an in vitro colonic fermentation model.

Authors:  C Cinquin; G Le Blay; I Fliss; C Lacroix
Journal:  Microb Ecol       Date:  2004-04-19       Impact factor: 4.552

2.  Microbial community development in a dynamic gut model is reproducible, colon region specific, and selective for Bacteroidetes and Clostridium cluster IX.

Authors:  Pieter Van den Abbeele; Charlotte Grootaert; Massimo Marzorati; Sam Possemiers; Willy Verstraete; Philippe Gérard; Sylvie Rabot; Aurélia Bruneau; Sahar El Aidy; Muriel Derrien; Erwin Zoetendal; Michiel Kleerebezem; Hauke Smidt; Tom Van de Wiele
Journal:  Appl Environ Microbiol       Date:  2010-06-18       Impact factor: 4.792

3.  Development and validation of a continuous in vitro system reproducing some biotic and abiotic factors of the veal calf intestine.

Authors:  Marie Gérard-Champod; Stéphanie Blanquet-Diot; Jean-Michel Cardot; David Bravo; Monique Alric
Journal:  Appl Environ Microbiol       Date:  2010-06-25       Impact factor: 4.792

4.  Development and validation of the Simulator of the Canine Intestinal Microbial Ecosystem (SCIME)1.

Authors:  Cindy Duysburgh; Wendy P Ossieur; Kim De Paepe; Pieter Van den Abbeele; Ramiro Vichez-Vargas; Marius Vital; Dietmar H Pieper; Tom Van de Wiele; Myriam Hesta; Sam Possemiers; Massimo Marzorati
Journal:  J Anim Sci       Date:  2020-01-01       Impact factor: 3.159

Review 5.  A review of the advancements in probiotic delivery: Conventional vs. non-conventional formulations for intestinal flora supplementation.

Authors:  Mershen Govender; Yahya E Choonara; Pradeep Kumar; Lisa C du Toit; Sandy van Vuuren; Viness Pillay
Journal:  AAPS PharmSciTech       Date:  2013-09-25       Impact factor: 3.246

Review 6.  Application of in vitro gut fermentation models to food components: A review.

Authors:  Jin Seok Moon; Ling Li; Jeongsu Bang; Nam Soo Han
Journal:  Food Sci Biotechnol       Date:  2016-03-31       Impact factor: 2.391

Review 7.  Engineering bacteria for diagnostic and therapeutic applications.

Authors:  David T Riglar; Pamela A Silver
Journal:  Nat Rev Microbiol       Date:  2018-02-05       Impact factor: 60.633

8.  Use of a combination of in vitro models to investigate the impact of chlorpyrifos and inulin on the intestinal microbiota and the permeability of the intestinal mucosa.

Authors:  Marina Réquilé; Dubàn O Gonzàlez Alvarez; Stéphane Delanaud; Larbi Rhazi; Véronique Bach; Flore Depeint; Hafida Khorsi-Cauet
Journal:  Environ Sci Pollut Res Int       Date:  2018-05-28       Impact factor: 4.223

Review 9.  Gut microbiome in neuroendocrine and neuroimmune interactions: The case of genistein.

Authors:  Tai L Guo; Yingjia Chen; Hannah Shibo Xu; Callie M McDonough; Guannan Huang
Journal:  Toxicol Appl Pharmacol       Date:  2020-07-14       Impact factor: 4.219

10.  Use of a continuous-flow anaerobic culture to characterize enteric virulence gene expression.

Authors:  Fernando Ruiz-Perez; Jalaluddin Sheikh; Suzanne Davis; Edgar C Boedeker; James P Nataro
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.